Zdrowie i gospodarka · 29/06/2001

FDA Submits Information Collection Activities for OMB Review and Comment Request

The Food and Drug Administration (FDA) is announcing that the proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, in response to a request for public comment on proposed changes to patent term restoration, due diligence petitions, and the filing, format, and content of petitions.